In outpatient diuresis for edema in HF and CKD,
the simplicity of autoinjection meets complete bioavailability.
*
FUROSCIX is not for chronic use and should be replaced with oral diuretics as soon as practical. “In the presence of fluid overload” was established in a study conducted using the FUROSCIX On-Body Infusor. FUROSCIX ReadyFlow complete bioavailability was established in a study conducted using healthy volunteers.
CKD=chronic kidney disease; HF=heart failure.